Amylyx Pharmaceuticals, Inc.

AMLX · Nasdaq · SIC 2834: Pharmaceutical Preparations
77
SEC Filings

Business Summary

PART I . Overview Amylyx Pharmaceuticals, Inc. (also referred to as Amylyx, we, our or us) is a clinical-stage pharmaceutical company with a mission to develop and advance novel therapies for communities with high unmet medical needs. We have preclinical and clinical development programs underway in endocrine conditions and neurodegenerative diseases. We are advancing a pipeline in which we have matched investigational therapies with diseases for which we believe these therapies can make the gre...

Next Earnings

Q2 FY2026 — expected 2026-09-11

Key Facts from Earnings Calls

TypeSubjectDetailQuarter
topic_mentionAMLXdiscussed_in_filing Cybersecurity
topic_mentionAMLXdiscussed_in_filing Cybersecurity
topic_mentionAMLXdiscussed_in_filing Healthcare & Bio
topic_mentionAMLXdiscussed_in_filing Healthcare & Bio

Annual Reports (10-K)

FiledPeriodAccessionSourceFull Text
2026-03-032025-12-310001193125-26-086645EDGAR99K words
2025-03-042024-12-310000950170-25-031309EDGAR—
2024-02-222023-12-310000950170-24-018447EDGAR—
2023-03-132022-12-310000950170-23-007609EDGAR—
2022-03-312021-12-310000950170-22-005157EDGAR—

Quarterly Reports (10-Q)

FiledPeriodAccessionSourceFull Text
2025-11-062025-09-300001193125-25-268059EDGAR72K words
2025-08-072025-06-300001193125-25-174948EDGAR—
2025-05-082025-03-310000950170-25-066363EDGAR—
2024-11-072024-09-300000950170-24-122833EDGAR—
2024-08-082024-06-300000950170-24-093311EDGAR—
2024-05-092024-03-310000950170-24-056269EDGAR—
2023-11-092023-09-300000950170-23-061516EDGAR—
2023-08-102023-06-300000950170-23-041335EDGAR—
2023-05-112023-03-310000950170-23-021369EDGAR—
2022-11-102022-09-300000950170-22-024465EDGAR—
2022-08-112022-06-300000950170-22-016883EDGAR—
2022-05-122022-03-310000950170-22-009695EDGAR—

Recent Current Reports (8-K)

FiledAccessionSourceFull Text
2026-03-240001193125-26-120691EDGAR7K words
2026-03-030001193125-26-086629EDGAR—
2026-01-080001193125-26-006991EDGAR—
2025-11-060001193125-25-268043EDGAR—
2025-09-100001193125-25-200159EDGAR—
2025-08-270001193125-25-189109EDGAR—
2025-08-070000950170-25-104546EDGAR—
2025-06-050001193125-25-135860EDGAR—
2025-05-080000950170-25-066355EDGAR—
2025-03-040000950170-25-031303EDGAR—

77 total filings indexed. 50 additional filings (S-1, DEF 14A, etc.) View all (JSON) · SEC EDGAR

Sector Peers

SXTP — 60 DEGREES PHARMACEUTICALS, INC. ABT — ABBOTT LABORATORIES ABEO — ABEONA THERAPEUTICS INC. ABVC — ABVC BIOPHARMA, INC. ACAD — ACADIA PHARMACEUTICALS INC ACTU — ACTUATE THERAPEUTICS, INC. ADCT — ADC Therapeutics SA ADIL — ADIAL PHARMACEUTICALS, INC.

Company Identity

CIK0001658551
TickerAMLX
ExchangeNasdaq
SIC2834: Pharmaceutical Preparations
IncorporatedDE

Get More Data

This is the free public profile. For structured JSON with full provenance chain, use the API:

JSON Profile Stock Quote AI Readiness Report
Origin Provenance
page leaf: 5e56ec6b4090965bfbe112bc44d9d1346f29740320325df0a0520bca02b3842f
parent: 4e22118e2121d162c6fa1f36328d2adf22d17574eb6a26a20daa2aae8961b83f
content hash: 1602c6d935bd9570b08f92ce95ad5aed9144b6bad0c857e4819e0a403ae1d0a7
signed: 2026-04-13T04:43:37.769Z
sources: 17 verified data leaves
chain: SEC.gov PEM → origin.rootz.global extraction → this page
verify: sha256(content_hash + parent + timestamp) = leaf